DLB - Dolby Laboratories Inc Stock Price, Fair Value and News

79.92USD+0.34 (+0.43%)Market Closed

Market Summary

USD79.92+0.34

Market Closed

0.43%

DLB Stock Price

View Fullscreen

DLB RSI Chart

DLB Valuation

Market Cap

7.6B

Price/Earnings (Trailing)

40.32

Price/Sales (Trailing)

5.93

EV/EBITDA

22.21

Price/Free Cashflow

26.18

DLB Price/Sales (Trailing)

DLB Profitability

Operating Margin

88.27%

EBT Margin

18.03%

Return on Equity

8.03%

Return on Assets

6.41%

Free Cashflow Yield

3.82%

DLB Fundamentals

DLB Revenue

Revenue (TTM)

1.3B

Rev. Growth (Yr)

-5.78%

Rev. Growth (Qtr)

8.61%

DLB Earnings

Earnings (TTM)

188.3M

Earnings Growth (Yr)

-15.61%

Earnings Growth (Qtr)

629.16%

Breaking Down DLB Revenue

Last 7 days

2.0%

Last 30 days

-4.4%

Last 90 days

-6.0%

Trailing 12 Months

-3.5%

How does DLB drawdown profile look like?

DLB Financial Health

Current Ratio

3.68

DLB Investor Care

Dividend Yield

1.41%

Dividend/Share (TTM)

1.11

Buy Backs (1Y)

0.55%

Diluted EPS (TTM)

1.93

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	1.3B	1.3B	1.3B	1.3B
2022	1.3B	1.3B	1.3B	1.2B
2021	1.2B	1.3B	1.3B	1.2B
2020	1.2B	1.2B	1.2B	1.3B
2019	1.1B	1.2B	1.2B	1.2B
2018	1.1B	1.1B	1.1B	1.1B
2017	1.0B	1.1B	1.1B	1.1B
2016	979.6M	1.0B	1.0B	1.1B
2015	956.5M	964.8M	970.6M	977.2M
2014	933.6M	949.9M	960.2M	963.1M
2013	922.0M	918.8M	909.7M	904.3M
2012	959.7M	951.0M	933.0M	935.4M
2011	950.8M	939.5M	955.5M	947.0M
2010	821.1M	871.9M	922.7M	944.2M
2009	0	679.9M	719.5M	770.3M
2008	0	0	640.2M	0

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Dolby Laboratories Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 01, 2024	rollins emily	sold	-80,880	80.88	-1,000	-
Feb 28, 2024	pendleton todd	sold	-1,992,800	81.6888	-24,395	svp, chief marketing officer
Feb 28, 2024	pendleton todd	acquired	844,997	70.2876	12,022	svp, chief marketing officer
Feb 09, 2024	couling john d	sold	-2,711,900	80.8074	-33,560	svp, entertainment
Feb 09, 2024	couling john d	acquired	1,850,870	55.1511	33,560	svp, entertainment
Feb 08, 2024	couling john d	sold	-4,000,000	80.00	-50,000	svp, entertainment
Feb 08, 2024	couling john d	acquired	2,149,000	42.98	50,000	svp, entertainment
Feb 06, 2024	gotcher peter c	acquired	-	-	2,952	-
Feb 06, 2024	dolby david	acquired	-	-	2,952	-
Feb 06, 2024	prophet tony a	acquired	-	-	2,952	-

Which funds bought or sold DLB recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	RICE HALL JAMES & ASSOCIATES, LLC	reduced	-38.58	-314,611	466,180	0.03%
Apr 23, 2024	Venturi Wealth Management, LLC	reduced	-96.46	-906,318	32,274	-%
Apr 23, 2024	AMALGAMATED BANK	reduced	-21.02	-821,000	2,710,000	0.02%
Apr 23, 2024	Louisiana State Employees Retirement System	added	2.4	-6,739	1,432,470	0.03%
Apr 23, 2024	Gradient Investments LLC	reduced	-23.81	-1,408	4,021	-%
Apr 23, 2024	Global Retirement Partners, LLC	reduced	-79.49	-5,262	1,340	-%
Apr 23, 2024	NEW MEXICO EDUCATIONAL RETIREMENT BOARD	unchanged	-	-29,000	1,014,000	0.04%
Apr 23, 2024	FIFTH THIRD BANCORP	reduced	-14.59	-8,926	43,644	-%
Apr 23, 2024	Creative Capital Management Investments LLC	unchanged	-	-43.00	1,508	-%
Apr 22, 2024	Harfst & Associates, Inc.	sold off	-100	-1,972,140	-	-%

Are Funds Buying or Selling DLB?

Are funds buying DLB calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own DLB

No. of Funds

Unveiling Dolby Laboratories Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	10.80%	6,394,750	SC 13G/A
Feb 13, 2024	kayne anderson rudnick investment management llc	9.19%	5,420,205	SC 13G/A
Feb 08, 2024	morgan stanley	7.8%	4,593,133	SC 13G/A
Jan 24, 2024	blackrock inc.	9.8%	5,797,685	SC 13G/A
Mar 10, 2023	vanguard group inc	10.06%	6,012,094	SC 13G/A
Feb 14, 2023	kayne anderson rudnick investment management llc	8.54%	5,110,252	SC 13G
Feb 10, 2023	clearbridge investments, llc	4.8%	2,903,393	SC 13G/A
Feb 09, 2023	morgan stanley	7.1%	4,261,695	SC 13G/A
Feb 09, 2023	vanguard group inc	9.94%	5,963,672	SC 13G/A
Feb 03, 2023	blackrock inc.	5.2%	3,117,785	SC 13G

Recent SEC filings of Dolby Laboratories Inc

View All Filings

Date Filed	Form Type	Document
Mar 05, 2024	4	Insider Trading
Mar 01, 2024	144	Notice of Insider Sale Intent
Mar 01, 2024	4	Insider Trading
Feb 28, 2024	144	Notice of Insider Sale Intent
Feb 14, 2024	4	Insider Trading
Feb 13, 2024	SC 13G/A	Major Ownership Report
Feb 13, 2024	SC 13G/A	Major Ownership Report
Feb 12, 2024	4	Insider Trading
Feb 12, 2024	4/A	Insider Trading
Feb 09, 2024	144	Notice of Insider Sale Intent

Peers (Alternatives to Dolby Laboratories Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ADP	101.3B	18.6B	0.99%	16.50%	28.48	5.45	7.76%	13.08%
CTAS	67.4B	9.4B	4.48%	48.57%	44.82	7.16	9.34%	15.98%
CPRT	52.8B	4.1B	-3.93%	41.68%	38.94	13.01	10.52%	25.37%
EFX	27.9B	5.4B	-13.50%	14.03%	50.04	5.21	5.76%	-4.95%
BAH	18.7B	10.3B	-1.18%	50.22%	45.77	1.81	13.90%	-5.05%
ALLE	11.1B	3.7B	-4.79%	24.13%	20.5	3.03	11.58%	17.98%
MID-CAP
RHI	7.5B	6.4B	-8.74%	-0.28%	18.3	1.18	-11.68%	-37.51%
AL	5.7B	2.7B	4.70%	34.09%	9.29	2.13	15.87%	733.47%
SRCL	4.6B	2.7B	-5.50%	16.61%	-216.73	1.74	-1.68%	-137.70%
ABM	2.8B	8.2B	1.71%	7.28%	10.95	0.34	3.98%	33.49%
SMALL-CAP
AZZ	1.9B	2.7B	8.63%	114.14%	21.53	0.69	104.63%	175.67%
ALTG	384.8M	1.9B	-6.98%	-16.41%	43.24	0.21	19.40%	-4.30%
ARC	118.5M	281.2M	1.85%	-8.94%	14.39	0.42	-1.68%	-25.77%
AQMS	53.7M	1.1M	2.13%	-58.97%	-2.24	49.78	336.95%	-55.13%
AWX	8.6M	80.5M	-8.33%	-18.22%	-4.77	0.11	-0.82%	-207.00%

Dolby Laboratories Inc News

Latest updates

Dolby Laboratories Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	8.6%	316	291	298	376	335	278	290	334	352	285	287	320	390	271	247	352	292	299	302	338	302
Cost Of Revenue	-9.8%	32.00	36.00	42.00	41.00	34.00	37.00	36.00	36.00	33.00	31.00	32.00	32.00	35.00	42.00	30.00	37.00	37.00	46.00	40.00	37.00	39.00
Gross Profit	11.2%	284	255	257	335	300	241	254	299	319	254	255	287	355	229	217	315	255	253	262	302	264
Operating Expenses	-15.9%	217	259	241	226	206	214	208	256	228	214	199	204	190	199	183	209	206	202	228	199	195
S&GA Expenses	-13.1%	79.00	91.00	86.00	96.00	82.00	90.00	87.00	84.00	97.00	98.00	81.00	78.00	75.00	81.00	71.00	88.00	95.00	82.00	83.00	93.00	86.00
R&D Expenses	-4.8%	67.00	70.00	69.00	68.00	64.00	62.00	63.00	67.00	69.00	62.00	62.00	66.00	64.00	62.00	60.00	60.00	58.00	60.00	60.00	59.00	59.00
EBITDA Margin	-12.1%	0.24*	0.28*	0.28*	0.30*	0.25*	0.25*	0.26*	0.27*	0.31*	0.35*	0.35*	0.35*	0.35*	0.28*	-	-	-	-	-	-	-
Interest Expenses	-100.0%	-	28.00	0.00	-0.03	0.00	6.00	0.00	0.00	0.00	3.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Income Taxes	1592.7%	13.00	-0.89	7.00	21.00	21.00	3.00	10.00	7.00	11.00	-1.17	5.00	9.00	24.00	8.00	-27.40	22.00	6.00	12.00	2.00	36.00	-24.10
Earnings Before Taxes	794.9%	81.00	9.00	24.00	117	100	31.00	49.00	43.00	91.00	43.00	59.00	85.00	167	34.00	40.00	111	54.00	56.00	42.00	110	74.00
EBT Margin	-6.3%	0.18*	0.19*	0.21*	0.23*	0.18*	0.17*	0.18*	0.19*	0.22*	0.28*	0.27*	0.27*	0.28*	0.21*	-	-	-	-	-	-	-
Net Income	629.2%	67.00	9.00	16.00	96.00	79.00	28.00	40.00	37.00	80.00	44.00	55.00	76.00	135	27.00	67.00	88.00	49.00	44.00	40.00	73.00	98.00
Net Income Margin	-4.8%	0.15*	0.15*	0.17*	0.19*	0.15*	0.15*	0.16*	0.17*	0.21*	0.24*	0.23*	0.25*	0.25*	0.20*	-	-	-	-	-	-	-
Free Cashflow	-97.0%	2.00	77.00	114	97.00	49.00	41.00	161	51.00	17.00	98.00	159	70.00	67.00	102	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-1.5%	2,936	2,980	3,008	2,836	2,749	2,690	2,920	3,063	3,105	3,106	3,135	3,106	3,097	2,917	2,904	2,945	2,893	2,822	2,810	2,847	2,823
Current Assets	-2.4%	1,451	1,488	1,469	1,463	1,349	1,311	1,505	1,622	1,695	1,760	1,773	1,751	1,725	1,547	1,503	1,460	1,401	1,382	1,339	1,396	1,424
Cash Equivalents	-11.9%	657	745	765	688	631	628	867	909	1,064	1,233	1,227	1,113	1,119	1,080	863	734	753	806	724	735	800
Inventory	5.5%	38.00	36.00	32.00	30.00	26.00	24.00	24.00	17.00	13.00	11.00	12.00	15.00	20.00	26.00	29.00	28.00	29.00	32.00	39.00	35.00	28.00
Net PPE	-0.5%	479	482	502	508	512	513	518	528	534	534	538	543	544	542	547	551	549	537	525	538	523
Goodwill	0.5%	410	408	426	370	369	365	368	372	340	341	338	338	339	337	336	333	335	335	336	327	327
Liabilities	-5.7%	573	608	625	480	456	439	460	458	462	501	507	512	526	479	467	576	555	509	490	494	474
Current Liabilities	-6.7%	394	422	423	314	290	278	285	281	283	316	309	309	316	267	258	307	293	307	278	265	295
Shareholder's Equity	-0.4%	2,346	2,355	2,366	2,356	2,293	2,251	2,460	2,605	2,643	2,604	2,628	2,594	2,571	2,438	2,437	2,369	2,339	2,313	2,320	2,353	2,349
Retained Earnings	-1.0%	2,367	2,392	2,397	2,378	2,319	2,298	2,485	2,615	2,649	2,608	2,626	2,592	2,566	2,443	2,448	2,396	2,351	2,328	2,329	2,362	2,362
Additional Paid-In Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shares Outstanding	-0.4%	95.00	96.00	96.00	96.00	96.00	100	100	101	101	101	101	101	101	101	101	101	100	102	101	102	103
Minority Interest	-3.6%	16.00	17.00	16.00	5.00	5.00	5.00	5.00	5.00	5.00	6.00	6.00	6.00	6.00	6.00	6.00	5.00	5.00	6.00	6.00	6.00	6.00
Float	-	-	-	-	4,100	-	-	-	4,600	-	-	-	5,700	-	-	-	3,100	-	-	-	3,200	-

Cashflow (Last 12 Months)

(In Millions)

Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-90.1%	8.00	85.00	121	105	56.00	51.00	173	63.00	32.00	110	172	83.00	82.00	113	134	66.00	31.00	130	91.00	49.00	57.00
Share Based Compensation	13.1%	32.00	28.00	29.00	30.00	31.00	27.00	28.00	28.00	33.00	24.00	25.00	24.00	26.00	22.00	21.00	21.00	23.00	17.00	19.00	19.00	21.00
Cashflow From Investing	103.2%	1.00	-19.71	22.00	24.00	28.00	-40.72	-8.16	-120	-126	-14.96	-14.19	-14.26	-1.50	155	27.00	-9.80	-37.41	17.00	-9.87	-21.89	-41.57
Cashflow From Financing	-192.4%	-125	-42.80	-36.83	-67.10	-90.09	-242	-197	-97.42	-72.84	-86.86	-44.88	-74.43	-46.34	-53.86	-37.43	-68.21	-48.28	-62.70	-91.13	-93.02	-138
Dividend Payments	10.6%	29.00	26.00	26.00	26.00	26.00	24.00	25.00	25.00	25.00	22.00	22.00	22.00	22.00	22.00	22.00	22.00	22.00	19.00	19.00	19.00	20.00
Buy Backs	220.0%	80.00	25.00	25.00	50.00	49.00	220	190	85.00	36.00	96.00	39.00	71.00	40.00	45.00	27.00	72.00	30.00	54.00	89.00	85.00	113

DLB Income Statement

2023-12-29

Interim Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Dec. 29, 2023	Dec. 30, 2022
Revenue:
Revenue	$ 315,574	$ 334,921
Total revenue	315,574	334,921
Cost of revenue:
Total cost of revenue	32,060	34,450
Gross profit	283,514	300,471
Operating expenses:
Research and development	67,033	64,450
Sales and marketing	79,003	82,205
General and administrative	65,166	59,972
Restructuring charges	6,091	(244)
Total operating expenses	217,293	206,383
Operating income	66,221	94,088
Other income/(expense):
Interest income/(expense), net	9,187	4,797
Other income, net	5,425	1,097
Total other income	14,612	5,894
Income before income taxes	80,833	99,982
Provision for income taxes	(13,252)	(20,534)
Net income including noncontrolling interest	67,581	79,448
Less: net income attributable to noncontrolling interest	(600)	(73)
Net income attributable to Dolby Laboratories, Inc.	$ 66,981	$ 79,375
Net income per share:
Basic (in usd per share)	$ 0.70	$ 0.83
Diluted (in usd per share)	$ 0.69	$ 0.82
Weighted-average shares outstanding:
Basic (in shares)	95,376	95,905
Diluted (in shares)	97,439	97,047
Cash dividend declared per common share (in dollars per share)	$ 0.30	$ 0.27
Cash dividend paid per common share (in dollars per share)	$ 0.30	$ 0.27
Licensing
Revenue:
Revenue	$ 293,767	$ 308,011
Cost of revenue:
Cost of revenue	15,736	13,359
Products and services
Revenue:
Revenue	21,807	26,910
Cost of revenue:
Cost of revenue	$ 16,324	$ 21,091

DLB Balance Sheet

2023-12-29

Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 29, 2023	Sep. 29, 2023
Current assets:
Cash and cash equivalents	$ 656,816	$ 745,364
Restricted cash	51,842	72,602
Short-term investments	140,823	139,148
Accounts receivable, net of allowance for credit losses of $7,428 and $9,683	293,228	262,245
Contract assets, net of allowance for credit losses of $108 and $138	217,559	182,130
Inventories, net	37,568	35,623
Prepaid expenses and other current assets	53,519	50,692
Total current assets	1,451,355	1,487,804
Long-term investments	92,876	97,812
Property, plant, and equipment, net	479,321	481,581
Operating lease right-of-use assets	38,001	40,199
Intangible assets, net	159,894	167,427
Goodwill	410,435	408,409
Other non-current assets	96,980	94,674
Deferred taxes	206,667	201,860
Total assets	2,935,529	2,979,766
Current liabilities:
Accounts payable	14,395	20,925
Accrued liabilities	327,186	351,399
Income taxes payable	6,189	4,769
Contract liabilities	33,404	31,505
Operating lease liabilities	12,922	13,628
Total current liabilities	394,096	422,226
Non-current contract liabilities	36,994	39,997
Non-current operating lease liabilities	34,319	37,020
Other non-current liabilities	107,810	108,339
Total liabilities	573,219	607,582
Stockholders’ equity:
Retained earnings	2,367,182	2,391,990
Accumulated other comprehensive loss	(21,428)	(36,984)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,345,848	2,355,100
Noncontrolling interest	16,462	17,084
Total stockholders’ equity	2,362,310	2,372,184
Total liabilities and stockholders’ equity	2,935,529	2,979,766
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 59,765,465 shares issued and outstanding at December 29, 2023 and 59,673,633 at September 29, 2023
Stockholders’ equity:
Common stock	53	53
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,085,779 shares issued and outstanding at December 29, 2023 and 36,085,779 at September 29, 2023
Stockholders’ equity:
Common stock	$ 41	$ 41

About Dolby Laboratories Inc

Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices. Its audio technologies also include DD, a digital audio coding technology that provides multichannel sound to applications; DD+, a digital audio coding technology that offers audio transmission for a range of media applications and devices; Dolby TrueHD, a digital audio coding technology providing encoding for media application; Dolby Vision, an imaging technology for cinema and media devices; Dolby Voice, an audio communications technology that emulates the in-person meeting experience; and HEVC, a digital video codec with high bandwidth efficiency for media devices. In addition, the company offers digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides 3-D glasses and kits; and various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. It sells its products directly to the end users, as well as through dealers and distributors worldwide. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.

CEO	Mr. Kevin J. Yeaman
WEBSITE	dolby.com
INDUSTRY	Information Technology Services
EMPLOYEES	2336

Dolby Laboratories Inc Frequently Asked Questions

What is the ticker symbol for Dolby Laboratories Inc? What does DLB stand for in stocks?

DLB is the stock ticker symbol of Dolby Laboratories Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Dolby Laboratories Inc (DLB)?

As of Wed Apr 24 2024, market cap of Dolby Laboratories Inc is 7.59 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DLB stock?

You can check DLB's fair value in chart for subscribers.

What is the fair value of DLB stock?

You can check DLB's fair value in chart for subscribers. The fair value of Dolby Laboratories Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Dolby Laboratories Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for DLB so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Dolby Laboratories Inc a good stock to buy?

The fair value guage provides a quick view whether DLB is over valued or under valued. Whether Dolby Laboratories Inc is cheap or expensive depends on the assumptions which impact Dolby Laboratories Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DLB.

What is Dolby Laboratories Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 24 2024, DLB's PE ratio (Price to Earnings) is 40.32 and Price to Sales (PS) ratio is 5.93. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DLB PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Dolby Laboratories Inc's stock?

In the past 10 years, Dolby Laboratories Inc has provided 0.07 (multiply by 100 for percentage) rate of return.